IL-33 induces nuocytes and modulates liver injury in viral hepatitis.
about
The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune ResponseEndogenous IL-33 Deficiency Exacerbates Liver Injury and Increases Hepatic Influx of Neutrophils in Acute Murine Viral HepatitisThe Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases.Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation.Strong type 1, but impaired type 2, immune responses contribute to Orientia tsutsugamushi-induced pathology in mice.Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.Interleukin-33 in Tissue Homeostasis, Injury, and InflammationIL-33-Dependent Endothelial Activation Contributes to Apoptosis and Renal Injury in Orientia tsutsugamushi-Infected MiceType 1 interferon-induced IL-7 maintains CD8+ T-cell responses and homeostasis by suppressing PD-1 expression in viral hepatitisThe role of IL-33 in rheumatic diseasesRegulation of metabolic health and adipose tissue function by group 2 innate lymphoid cellsIL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosisThe Role of IL-33-Dependent Inflammation in the Tumor Microenvironment.Intrahepatic innate lymphoid cells secrete IL-17A and IL-17F that are crucial for T cell priming in viral infection.IFN-γ directly controls IL-33 protein level through a STAT1- and LMP2-dependent mechanism.The route to pathologies in chronic inflammatory diseases characterized by T helper type 2 immune cells.Group 2 innate lymphoid cells in health and disease.Pivotal roles of ILCs in hepatic diseases.Group 2 innate lymphoid cells in disease.Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.Retinoic Acid Regulates Immune Responses by Promoting IL-22 and Modulating S100 Proteins in Viral Hepatitis.Intrahepatic regulation of antiviral T cell responses at initial stages of viral infection.Adverse outcome pathway development from protein alkylation to liver fibrosis.Emerging concepts in biliary repair and fibrosis.IL-33 promotes innate IFN-γ production and modulates dendritic cell response in LCMV-induced hepatitis in miceOncostatin M induces IL-33 expression in liver endothelial cells in mice and expands ST2+CD4+ lymphocytes.Expression and potential roles of IL-33/ST2 in the immune regulation during Clonorchis sinensis infection.Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation.Type 1 innate lymphoid cells contribute to the pathogenesis of chronic hepatitis B.IL-33-ST2 Axis in Liver Disease: Progression and Challenge.Unconventional Pro-inflammatory CD4+ T Cell Response in B Cell-Deficient Mice Infected with Trypanosoma cruzi.Dysregulated Th1 Immune and Vascular Responses in Scrub Typhus Pathogenesis.Overexpression of interleukin-33 is associated with poor prognosis of patients with glioma.Ambiguous roles of innate lymphoid cells in chronic development of liver diseases.
P2860
Q26743383-A368E8FC-33FC-47AA-9088-55E681A97149Q33760241-7038A7C2-BE8E-468A-B8EB-8DE1721FE495Q33790954-ADEC8B8D-CA3E-4BE2-A0FE-08BAAFFBB7A9Q33808159-1466F8D7-D584-4053-9FA8-422DA370E588Q34257323-C29FABFE-72BE-4861-933D-98E4648EC91DQ35439783-F96466F5-7122-48D3-90BF-3E076E5CF724Q35754479-A7529B69-3D64-40A6-BEB7-8663998E0E65Q35946057-71CB7BAB-E069-4771-AEAD-A63741B7A590Q36302605-936CDF3B-455D-4C5C-AEB7-9DA82C9D383BQ37208870-982543D5-B489-4BE9-B865-856EB2BCF018Q37313634-E5A6F7B3-757E-4764-976E-6052DFA5345AQ37376114-2E5157AD-A5A8-4CEE-9861-747D4226F609Q37571181-B2F5EC7C-7700-4686-BA56-F64F902A9DD8Q37668196-DC20F799-4647-4C26-ACAB-ACF75D8B146DQ37727601-81693890-173B-4561-A42E-DBDC91A081F8Q38224933-BE291155-2B6A-4472-9A80-4396C5BF3242Q38312434-B9CDCD8F-B8C1-4C56-8B69-00AB48F7D8AFQ38366661-45A82E9F-6A91-46E7-9F95-30523DE77315Q38573631-CAAD21A6-7827-4C49-9A8B-536958546338Q38810636-62CEE5DD-BF3D-4766-A68A-05DC0BC35FE4Q38863916-40419951-1186-4B79-9430-D470D4F57D4BQ38908828-4C0583F6-9293-448A-BB9A-9266B536597BQ38932043-B79EBBDC-50B0-4E2B-B03F-AEC6EAC80BEDQ39319145-524D8DE0-8B76-4866-BB98-8ED71A8451CFQ39673177-9F470E36-328F-4C9F-B706-67B06166D8ACQ40649385-E3880FA4-D18A-4B3F-B3DF-6DAB15CA0EFFQ40767311-16DD3D37-60C1-4A3D-848F-28DA2AC0F729Q41149769-FB0977B5-D24F-42A6-84FD-5A7DF0C6BE31Q41228712-A1903527-F428-4F43-BC89-AA72FAC0640DQ47127784-3AE1CA55-146D-4EBA-8E39-D431E4D3C08CQ47162312-7DB6DCFC-0163-4330-829E-09A9355FA220Q50066285-A4B87F0B-8B12-4EB7-8F89-465CD71C50D7Q52141871-A70C0203-52EB-4322-86F1-9F510DEE5ECCQ55208795-1212B22B-D046-4F8D-B3F6-73AA21DEEAEB
P2860
IL-33 induces nuocytes and modulates liver injury in viral hepatitis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
IL-33 induces nuocytes and modulates liver injury in viral hepatitis
@nl
IL-33 induces nuocytes and modulates liver injury in viral hepatitis.
@ast
IL-33 induces nuocytes and modulates liver injury in viral hepatitis.
@en
type
label
IL-33 induces nuocytes and modulates liver injury in viral hepatitis
@nl
IL-33 induces nuocytes and modulates liver injury in viral hepatitis.
@ast
IL-33 induces nuocytes and modulates liver injury in viral hepatitis.
@en
prefLabel
IL-33 induces nuocytes and modulates liver injury in viral hepatitis
@nl
IL-33 induces nuocytes and modulates liver injury in viral hepatitis.
@ast
IL-33 induces nuocytes and modulates liver injury in viral hepatitis.
@en
P2093
P2860
P3181
P356
P1476
IL-33 induces nuocytes and modulates liver injury in viral hepatitis
@en
P2093
Jiaren Sun
Lynn Soong
Renan Aguilar-Valenzuela
Zuliang Jie
P2860
P304
P3181
P356
10.4049/JIMMUNOL.1300117
P407
P577
2013-04-29T00:00:00Z